Students of the year 2008
- Andrea Autengruber AUSTRIA
supervisor: Dr. Bruder, HZI Braunschweig,
project: Characterization and manipulation of type II alveolar epithelial cell function in T cell mediated pulmonary inflammation
Final exam June 2012; Leibniz-Institute for environment-medical research (IUF), Particle-Cell-Interaction, Düsseldorf; Senior Clinical Research Associate (CRA), Regional Medical Advisor / MSL (Pneumology), GlaxoSmithKline GSK (residing in Braunschweig)
- Kiran Peddireddi (nee Bala) INDIA
supervisor: Prof. Dr Schulz, Virology, OE 5230,
project: Development of an animal model to test the in-vivo function of the Kaposi Sarcoma Herpes Virus K15 protein
Final exam November 2012; clinical data manager at MRC clinical trials unit at University College (UCL), London, UK
- Rajkumar Bhayadia INDIA
supervisor: Dr. Melk, Pediatric Nephrology, OE 6720,
project: The role of endothelial cellular senescence in endothelial dysfunction and cardiovascular disease
Final exam June 2014. Pediatric Hematology, MHH; now Leukemia research, Martin-Luther University, Halle
- Krishna Chaitanya Vallabhaneni INDIA
supervisor: Prof. Dr. Dumler, Nephrology, OE 6840,
project: Role of Urokinase receptor in mobilization and differentiation of mesenchymal stem cells: impact on blood vessel repair after vascular injury and organ transplantation
Final exam June 2012; Dec 2012 - April 2016 Postdoc Cancer Institute, UMMC, Jackson, Mississippi; May 2016- June 2017 Faculty member of Radiation Oncology, Department of Medicine, UMMC, Jackson, Mississippi, USA. From July 2017 Field Application Scientist for South East Territory at Nexcelom Bioscience, Raleigh-Durham, North Carolina, USA; since April 2019 Field Applications Scientists for Mid Atlantic and South East territory at Maxcyte Inc.
- Tamaryin Godinho PORTUGAL
supervisor: Prof. Dr. Baum, Experimental Hematology and Oncology, OE 6960,
project: Cell fate modification by reversible expression of signalling proteins
Final exam June 2013; Experimental Haematology, MHH; now associate Editor - Angewandte Chemie, Wiley-VCH, Weinheim
- Dirk Heckl GERMANY
supervisor: Prof. Dr. Baum, Experimental Hematology, OE 6960,
project: Correction of MPL deficiency by gene transfer
Final exam June 2011; Harvard Medical School, USA; Pediatric Hematology, MHH (group leader); now W2 professor for Experimental Pediatrics at the Martin-Luther University of Halle
- Yarua Jaimes VENEZUELA
supervisor: Prof. Dr. Blasczyk, Transfusion Medicine, OE 8350,
project: Decreasing the immunogenicity of cell based therapeutics by regulating the expression of HLA class II and adhesion molecules
Final exam November 2011; Immune Regulation, Deutsches Rheuma-Forschungzentrum (DRFZ), Berlin; since 2013 Fraunhofer institute for cell therapies and Immunology (Fraunhofer IZI) in Leipzig, since 2017 group leader
- Daniela Prochaska (nee Kieneke) GERMANY
supervisor: Prof. Dr. Sodeik, Virology, OE 5230;
project: Biochemical Characterization of the recruitment of host factors such as microtubule motors and importins to the capsid of Herpes-Simplex-Virus
Final exam June 2012; from 2013 Immungenetics (among head of lab), Transfusion Medicine, MHH; Manager Vaccine Production/Associate Director Operations at Burgwedel Biotech GmbH/ MSD Animal Health; since 2019 professor, Technical Biochemistry and Pharmacology, Hochschule für Angewandte Wissenschaften, Hamburg
- Annika Krämer-Kühl GERMANY
supervisor: Prof. Dr. Behrens/ Pof. Dr. Pöhlmann, Clinical Immunology and Rheumatology, OE 6830,
project: Tetherin and Vpu: Molecular studies and clinical relevance of a new potential therapeutic target in HIV-infection
Final exam November 2011; Infection Biology, German Primate Center, DPZ, Göttingen; from February 2013 R&D Boehringer Ingelheim Veterinary Research Center Hannover; from July 2019 Study Manager Clinical Operations, Roche, Mannheim
- Elena Lam GERMANY
supervisor: Prof. Dr. Heim, Virology, OE 5230,
project: Virulence factors of pneumotropic adenovirus types
Final exam November 2011; Molecular Virology, Heinrich Pette Institute, Hamburg; from 2016 Process Engineer, IDT-Biologika, Dessau-Rosslau
- Hui Zhi Low SINGAPORE
supervisor: Prof. Dr. Witte, Clinical Immunology and Rheumatology, OE 6830,
project: Investigation into the role of ILT6 in immunomodulation and in autoimmune diseases and cancer
Final exam June 2012; Clinic for Immunology and Rheumatology, MHH; now Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine, Hannover
- Aliaksandra Maroz BELARUS
supervisor: Dr. Klusmann, Pediatric Hematology and Oncology, OE 6780,
project: Molecular mechanism of GATA1s-mediated malignant transformation of fetal hematopoietic stem and progenitor cells
Final exam November 2012; from 2013 Scientific Manager at Sysmex Europe GmbH, Hamburg; obtained an MBA degree from the Frankfurt School of Finance and Management in 2017; from 2018 Business Development Manager at Sysmex Europe; from May 2019 Specialist Global Business Intelligence and Development, Eppendorf AG, Hamburg
- Martin May GERMANY
supervisor: Dr. Genth, Toxicology, OE 5340,
project: Consequences of cytokinesis inhibition by bacterial toxins
Final exam November 2011; Toxicology MHH, Fraunhofer Institute ITEM Hannover, now Manager Scientific Affairs, BODE Chemie GmbH, Hamburg
- Vanessa Melhorn GERMANY
supervisor: Dr. Bohne, Virology, OE 5230,
project: Regulation of retroviral RNA export: an interplay of quality control and processing signals
Final exam June 2012; Virology MHH, coordinator of SFB; from 2017 scientific project manager for TI Epidemiology in DZIF, HZI Braunschweig
- Pooja Mishra INDIA
supervisor: Prof. Dr. Förster, Immunology, OE 5240,
project: The spatio-temporal distribution of regulatory T cells during chronic organ rejection
Final exam June 2012; from 09/13 Canada, Vancouver (at Stemcell Technologies as Program Associate); from 2016 Program manager, Stemcell technologies Inc., Vancouver, Canada
- Dhaarini Murugan INDIA
superrvisor: Prof. Dr. Klein, Pediatric Hemnatology and Oncology, OE 6780,
project: Investigation of the functional role of IL10R2 in the hematopoietic system and the deficient state being a potential cause of immune disorder in Inflammatory Bowel Disease
Final exam November 2013. Pediatrics, University Hospital Munich; now Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, USA
- Nils Pfaff GERMANY
supervisor: Prof. Dr. Moritz, REBIRTH, OE 8880,
project: Generation of induced pluripotent stem cells with hematopoietic origin
Final exam November 2011; REBIRTH MHH; from 2013 lab head Cardiogenomics, Bayer HealthCare, Wuppertal
- Tim Ripperger (Dr.med.) GERMANY
supervisor: Prof. Dr. Schlegelberger, Cell-/ Molecular Pathology, OE 5120,
project: Investigation of the ETS-transcription factor GABP
Final exam June 2013; Cell and Molecular Pathology (now Human genetics), MHH
- Volker Rust GERMANY
supervisor: Dr. B. Wölk, Virology, OE 5230,
project: Cellular factors governing hepatitis C virus replication complex formation and trafficking
Final exam November 2012; representative, Almirall Hermal, Reinbek (Hamburg); from 2015 Account Manager at Roche Diagnostics Deutschland; Marketing- und Produkt Manager Labordiagnostik, Roche Diagnostics Deutschland GmbH, Mannheim
- Ayesha Sultan INDIA
supervisor: Prof. Dr. Seidler, Gastroenterology/Hepatology/Endocrinology, OE 6810,
project: Unterstanding the molecular mechanisms for intestinal transport dysfunction in cystic fibrosis – role of PDZ adapter proteins and changes in signalling
Final exam June 2012; Institute of Physiology, University of Ulm; Postdoc in Boston, USA; maternity; now reintegration to research